Alexander Osmand, a Research Scientist in BCMB, was a co-author on a paper in the Proceedings of the National Academy of Sciences. This paper, Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition, examined the early phases of development of Huntington disease and a possible therapeutic intervention.
